The social media giant shows strong year-over-year (YoY) growth but is it enough for investors? In today's video, I look at fundamentals and recent earnings for Facebook (NASDAQ:FB), and below I share a few highlights from the video. On July 28, after the market closed, Facebook reported its Q2 2021 earnings.
The March reading comes as investors have continued to scale back their expectations on when the Federal Reserve will cut interest rates in 2024, if at all.
BASF SE (PNK:BASFY) Q1 2024 Earnings Call Transcript April 25, 2024 Stefanie Wettberg: Good morning, ladies and gentlemen. On behalf of BASF, I would like to welcome you to our conference call on the First Quarter 2024 Results. Throughout today’s recorded presentation, all participants will be in listen-only mode. The presentation will be followed by […]
"It dawned on me: They were utterly terrified we were going to discover something very exciting and powerful about our supposedly naughty bodies."
LOS ANGELES, April 26, 2024 (GLOBE NEWSWIRE) -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. PaxMedica (NASDAQ: PXMD), a biopharmaceutical company dedicated to advancing treatments for neurological disorders, takes center s
Chicago, April 26, 2024 (GLOBE NEWSWIRE) -- Fill Finish Manufacturing market in terms of revenue was estimated to be worth $16.7 billion in 2024 and is poised to reach $25.7 billion by 2029, growing at a CAGR of 8.9% from 2024 to 2029 according to a latest report published by MarketsandMarkets™. The major factors driving the growth of this fill finish manufacturing market include the increasing demand for biopharmaceuticals and vaccines. Additionally, advancements in technology such as automated
WEST PALM BEACH, FL, April 26, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today announced its preliminary unaudited revenue for the first quarter ended March 31, 2024. Financial Highlights: ●First Quarter Revenues were $488,587, a 38% increase over the $352,799 reported in the first quarter of 2023. ●First Quarter Gross Profit was $2
ATLANTA, April 26, 2024--Manhattan wins Overall Innovation of the Year award by RetailTech Breakthrough for it's latest offering, Fulfillment Experience Insights.
HOUSTON, April 26, 2024--Cheniere Declares Quarterly Dividend
April 26, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for theTreatment of Familial Adenomatous Polyposis (FAP) Worldwide rights come with $17 million in non-dilutive grant funding for Pivotal Phase 3 trial in FAP An estimated 100,000 in U.S. and Europe are afflicted with FAP, precancerous polyps that typically lead to surgical removal of the colon and/or rectum In FAP, eRapa holds the potential of delaying or
WEST HOLLYWOOD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (NASDAQ: BNIX) (“Bannix” or the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced that on April 25, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“NASDAQ”) advising the Company that the Company did
CHARLOTTE, N.C., April 26, 2024--IPERIONX TITANIUM HAMR FURNACE INSTALLATION COMPLETE
— If approved in the European Union, fruquintinib will be the first novel targeted therapy for metastatic colorectal cancer regardless of biomarker status in over a decade — — Positive opinion based on results from FRESCO-2 Phase III clinical trial — HONG KONG, SHANGHAI, China and FLORHAM PARK, N.J., April 26, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that its partner Takeda (TSE:4502/NYSE:TAK) received notification that the Com
OSAKA, Japan & CAMBRIDGE, Mass., April 26, 2024--Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when de
MUNICH, Germany, April 26, 2024 (GLOBE NEWSWIRE) -- Sono Group N.V. (the “Company”) (OTC: SEVCF), a solar technology company, today announced a correction to its press release issued on April 25, 2024, which provided an update on the trading symbol for the Company's ordinary shares and introduced the new leadership team. The original press release incorrectly stated that the Company's ordinary shares would be quoted on the over-the-counter market under the U.S. ticker symbol SEVC. Following addi
These Grants follow the receipt of a New Hampshire grant PORTLAND, April 26, 2024 (GLOBE NEWSWIRE) -- Shorepower Technologies, Inc. (OTC PINK: SPEV) (“Shorepower”), following it becoming a public company through its merger last March and receipt of funds in connection with the merger, has focused on bolstering its internal infrastructure, grant writing capabilities and sales. Shorepower is now pleased to announce that it has received two state grants in California. The wins are for facilities ba
TORONTO, April 26, 2024 (GLOBE NEWSWIRE) -- Mount Logan Capital Inc. (NEO: MLC) (“Mount Logan” or the “Company”) will release its financial results for the first quarter ended March 31, 2024 after market close on Thursday, May 9, 2024. The Company will host a conference call on Friday, May 10, 2024, at 11:00 a.m. Eastern Time to discuss these results. Shareholders, prospective shareholders, and analysts are welcome to listen to the conference call. To join the call, please use the dial-in inform
KUALA LUMPUR, Malaysia, April 26, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, “VCIG”, or the “Company”), is pleased to announce that it has scheduled an investor conference call at 8:00 a.m. Eastern Time on Tuesday, April 30th, 2024. “We are very excited and look forward to sharing with our investors the growth that our company has seen over this last year,” stated Dato’ Victor Hoo, Group Executive Chairman and Chief Executive Officer of VCI Global. Please call the
TORONTO, April 26, 2024 (GLOBE NEWSWIRE) -- Blockmate Ventures Inc (TSX.V: MATE) (FSE: 8MH1) (“Blockmate” or the “Company”) is pleased to provide an update on certain ongoing corporate initiatives. Midpoint DivestitureThe Company has completed its previously announced divestiture of Midpoint, its cross-border payments and foreign exchange business. The Midpoint business was assigned to David Wong, in consideration for the assumption of responsibility for all liabilities and obligations associate
Boca Raton, Florida, April 26, 2024 (GLOBE NEWSWIRE) -- IB Acquisition Corp. (NASDAQ: IBACU) (the “Company”) announced today that, on May 1, 2024, the Company’s units will no longer trade, and that the Company’s common stock and rights, which together comprise the units will commence trading separately. The common stock and rights will be listed on the Nasdaq Global Market and trade with the ticker symbols “IBAC” and “IBACR”, respectively. This is a mandatory and automatic separation, and no act
Yahoo Finance